These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 37234773)

  • 1. Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes.
    Hua L; Wu J; Ge J; Li X; You B; Wang W; Hu B
    Front Cell Dev Biol; 2023; 11():1060086. PubMed ID: 37234773
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma.
    Sun N; Luo Y; Zheng B; Zhang Z; Zhang C; Zhang Z; Zhang G; Tan F; Xue Q; Gao S; He J
    J Transl Med; 2022 Jul; 20(1):332. PubMed ID: 35879761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically relevant immune subtypes based on alternative splicing landscape of immune-related genes for lung cancer advanced PPPM approach.
    Li N; Jia W; Wang J; Shao Q; Feng X; Li Z; Sun W; Kang M; Hu D; Xing L; Zhan X
    EPMA J; 2024 Jun; 15(2):345-373. PubMed ID: 38841624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of the immunogenic cell death-related signature for predicting prognosis and immunotherapy efficiency in patients with lung adenocarcinoma.
    Cui Y; Li Y; Long S; Xu Y; Liu X; Sun Z; Sun Y; Hu J; Li X
    BMC Med Genomics; 2023 Aug; 16(1):184. PubMed ID: 37553698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
    Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q
    Front Immunol; 2021; 12():693062. PubMed ID: 34497605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An
    Han Y; Wong FC; Wang D; Kahlert C
    Cancer Inform; 2022; 21():11769351221100727. PubMed ID: 35645555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma.
    Jia H; Tang WJ; Sun L; Wan C; Zhou Y; Shen WZ
    Front Genet; 2022; 13():1017866. PubMed ID: 36699466
    [No Abstract]   [Full Text] [Related]  

  • 8. Construction and validation of a T cell proliferation regulator-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma.
    Chang W; Li H; Cheng Y; He H; Ou W; Wang SY
    Front Immunol; 2023; 14():1171145. PubMed ID: 37081889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinoma.
    Ma Y; Yang J; Ji T; Wen F
    Front Genet; 2022; 13():990623. PubMed ID: 36246622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis.
    Zhu M; Zeng Q; Fan T; Lei Y; Wang F; Zheng S; Wang X; Zeng H; Tan F; Sun N; Xue Q; He J
    Front Immunol; 2022; 13():783495. PubMed ID: 35222371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and clinical validation of a necroptosis-related gene signature for prediction of prognosis and tumor immunity in lung adenocarcinoma.
    Lei K; Tan B; Liang R; Lyu Y; Wang K; Wang W; Wang K; Hu X; Wu D; Lin H; Wang M
    Am J Cancer Res; 2022; 12(11):5160-5182. PubMed ID: 36504901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating subtypes of lung adenocarcinoma by oxidative stress and immunotherapy related genes.
    Duan G; Huang C; Zhao J; Zhang Y; Zhao W; Dai H
    Sci Rep; 2023 Nov; 13(1):20930. PubMed ID: 38017020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a copper metabolism-related gene signature in lung adenocarcinoma.
    Chang W; Li H; Zhong L; Zhu T; Chang Z; Ou W; Wang S
    Front Immunol; 2022; 13():1040668. PubMed ID: 36524120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma.
    Cao K; Ling X; Jiang X; Ma J; Zhu J
    Respir Res; 2022 Nov; 23(1):306. PubMed ID: 36357897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma.
    Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S
    Front Genet; 2022; 13():862741. PubMed ID: 35368663
    [No Abstract]   [Full Text] [Related]  

  • 16. A more novel and powerful prognostic gene signature of lung adenocarcinoma determined from the immune cell infiltration landscape.
    Ma C; Li F; He Z; Zhao S
    Front Surg; 2022; 9():1015263. PubMed ID: 36311939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases.
    Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y
    Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis and identification of subtypes and hub genes of high immune response in lung adenocarcinoma.
    Li H; Lei Y; Lai X; Huang R; Xiang Y; Zhao Z; Fang Z; Lai T
    BMC Pulm Med; 2024 Jul; 24(1):324. PubMed ID: 38965571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage-Related Gene Signatures for Predicting Prognosis and Immunotherapy of Lung Adenocarcinoma by Machine Learning and Bioinformatics.
    Xiang Y; Wang G; Liu B; Zheng H; Liu Q; Ma G; Du J
    J Inflamm Res; 2024; 17():737-754. PubMed ID: 38348277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinoma.
    Li Z; Wang W; Wu J; Ye X
    Front Med (Lausanne); 2022; 9():962972. PubMed ID: 36091687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.